Skip to main content

Migergot Side Effects

Generic name: caffeine / ergotamine

Medically reviewed by Drugs.com. Last updated on Apr 28, 2025.

Note: This document provides detailed information about Migergot Side Effects associated with caffeine / ergotamine. Some dosage forms listed on this page may not apply specifically to the brand name Migergot.

Applies to caffeine / ergotamine: oral tablet.

Other dosage forms:

Precautions

It is very important that your doctor check your progress at regular visits. This will allow your doctor to see if the medicine is working properly and to decide if you should continue to use it.

Using this medicine could harm your unborn baby. Use an effective form of birth control to keep from getting pregnant. Tell your doctor right away if you think you have become pregnant.

Do not use this medicine together with clarithromycin (Biaxin®), erythromycin (Erythrocin®), indinavir (Crixivan®), itraconazole (Sporanox®), ketoconazole (Nizoral®), nelfinavir (Viracept®), ritonavir (Norvir®), or troleandomycin (Tao®).

This medicine may be habit-forming. If you feel that the medicine is not working as well, do not use more than your prescribed dose. Call your doctor for instructions.

If you think you or someone else may have taken an overdose of this medicine, get emergency help at once. Signs of an overdose include: blurred vision, change in consciousness, dizziness, faintness, or lightheadedness when getting up suddenly from a lying position, headache, nervousness, numbness, tingling, pain, and bluish color of the fingernails, lips, skin, palms, or nail beds, loss of consciousness, pale, clammy skin, pounding in the ears, sweating, unusual tiredness or weakness, or vomiting.

This medicine may cause stomach problems (eg, retroperitoneal fibrosis). Check with your doctor right away if you have continuing or severe stomach pain, increased frequency of urination, continuing loss of appetite, lower back pain, continuing or severe nausea and vomiting, or weakness.

Check with your doctor right away if you have chest pain or tightness, or trouble breathing. These may be symptoms of a lung problem (eg, pleuropulmonary fibrosis).

Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.

Serious side effects of Migergot

Along with its needed effects, caffeine/ergotamine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking caffeine / ergotamine:

Incidence not known

  • chest pain, discomfort, or tightness
  • cold, pale, or a bluish color skin of the fingers or toes
  • continuing loss of appetite
  • continuing or severe nausea and vomiting
  • continuing or severe stomach pain
  • increased frequency of urination
  • irregular heartbeat
  • itching skin
  • lower back pain
  • numbness or tingling of the fingers or toes
  • pain in the fingers or toes
  • pain in arms legs, or lower back, especially pain in calves or heels upon exertion
  • sweating
  • swelling of hands, ankles, feet, or lower legs
  • weakness
  • weak or absent pulses in the legs

Get emergency help immediately if any of the following symptoms of overdose occur while taking caffeine / ergotamine:

Symptoms of overdose

Other side effects of Migergot

Some side effects of caffeine / ergotamine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Incidence not known

  • burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
  • dizziness or lightheadedness
  • feeling of constant movement of self or surroundings
  • sensation of spinning

For healthcare professionals

Applies to caffeine / ergotamine: oral tablet, rectal suppository.

General adverse events

The most commonly reported adverse effects have included nausea and vomiting.[Ref]

Gastrointestinal

Nervous system

Reports of cerebral ischemia, including 1 death, have been reported for patients receiving ergotamine and protease inhibitors concomitantly. A black box warning is now required labeling for these drugs.

Drug-induced headaches have been reported during prolonged and uninterrupted use. Withdrawal headaches have been reported with discontinuation after prolonged use.[Ref]

Cardiovascular

Serious vasoconstrictive have occurred, more commonly with long-term therapy at relatively high doses, however, they have been reported with short-term or normal doses.[Ref]

Respiratory

Musculoskeletal

Hypersensitivity

Ocular

Sudden and transient loss of vision have been reported, possibly due to vasospasm and ischemic episode.

Local

Solitary rectal or anal ulcer have occurred, usually at higher than recommended doses or with continuous use for many years[Ref]

Other

Dermatologic

See also:

References

1. Clementz GL, Dailey JW (1988) "Psychotropic effects of caffeine." Am Fam Physician, 37, p. 167-72

2. Sawynok J (1995) "Pharmacological rationale for the clinical use of caffeine." Drugs, 49, p. 37-50

3. Orton DA, Richardson RJ (1982) "Ergotamine absorption and toxicity." Postgrad Med J, 58, p. 6-11

4. Sanders SW, Haering N, Mosberg H, Jaeger H (1986) "Pharmacokinetics of ergotamine in healthy volunteers following oral and rectal dosing." Eur J Clin Pharmacol, 30, p. 331-4

5. Dahlof C (1993) "Placebo-controlled clinical trials with ergotamine in the acute treatment of migraine." Cephalalgia, 13, p. 166-71

6. Hokkanen E, Waltimo O, Kallanranta T (1978) "Toxic effects of ergotamine used for migraine." Headache, 18, p. 95-8

7. Merello MJ, Nogues MA, Leiguarda RC, Lopez Saubidet C (1991) "Dystonia and reflex sympathetic dystrophy induced by ergotamine." Mov Disord, 6, p. 263-4

8. Redfield MM, Nicholson WJ, Edwards WD, Tajik AJ (1992) "Valve disease associated with ergot alkaloid use: echocardiographic and pathologic correlations." Ann Intern Med, 117, p. 50-2

9. Ibraheem JJ, Paalzow L, Tfelt-Hansen P (1985) "Linear pharmacokinetics of intravenous ergotamine tartrate." Eur J Clin Pharmacol, 29, p. 61-6

10. Benedict CR, Robertson D (1979) "Angina pectoris and sudden death in the absence of atherosclerosis following ergotamine therapy for migraine." Am J Med, 67, p. 177-8

11. Zicot M, Grandfils F, Honore D (1978) "Prolonged arterial hemodynamic disturbances in the lower limbs after oral use of ergotamine." Angiology, 29, p. 495-6

12. Pusey CD, Rainford DJ (1977) "St Anthony's fire and pseudochronic renal failure." Br Med J, 2, p. 935

13. Klein LS, Simpson RJ, Jr Stern R, Hayward JC, Foster JR (1982) "Myocardial infarction following administration of sublingual ergotamine." Chest, 82, p. 375-6

14. Stillman AE, Weinberg M, Mast WC, Palpant S (1977) "Ischemic bowel disease attributable to ergot." Gastroenterology, 72, p. 1336-7

15. Bondeson J, Ericsson UB, Falke P, Mattiasson I, Nyman U, Lindell E, Bernow J (1992) "Tongue necrosis in temporal arteritis provoked by ergotamine." J Intern Med, 232, p. 541-4

16. Gupta DR, Strobos RJ (1972) "Bilateral papillitis associated with Cafergot therapy." Neurology, 22, p. 793-7

17. Fincham RW, Perdue Z, Dunn VD (1985) "Bilateral focal cortical atrophy and chronic ergotamine abuse." Neurology, 35, p. 720-2

18. Mintz U, Bar-Meir S, De Vries A (1974) "Ergotamine-induced venous thrombosis." Postgrad Med J, 50, p. 244-6

19. Lindboe CF, Dahl T, Rostad B (1989) "Fatal stroke in migraine: a case report with autopsy findings." Cephalalgia, 9, p. 277-80

20. Lepage-Savary D, Vallieres A (1982) "Ergotamine as a possible cause of retroperitoneal fibrosis." Clin Pharm, 1, p. 179-80

21. Bernstein AL (1987) "More on ergotamine withdrawal ." Headache, 27, p. 458

22. Deviere J, Reuse C, Askenasi R (1987) "Ischemic pancreatitis and hepatitis secondary to ergotamine poisoning." J Clin Gastroenterol, 9, p. 350-2

23. Taal BG, Spierings EL, Hilvering C (1983) "Pleuropulmonary fibrosis associated with chronic and excessive intake of ergotamine." Thorax, 38, p. 396-8

24. Mathew NT (1993) "Chronic refractory headache." Neurology, 43, s26-33

25. Allen MB, Tosh G, Walters G, Muers MF (1994) "Pleural and pericardial fibrosis after ergotamine therapy." Respir Med, 88, p. 67-9

Further information

Migergot side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.